By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeoStem, Inc. 

420 Lexington Ave, Suite 350

New York  New York  10170  U.S.A.
Phone: 212-584-4180 Fax: 425-696-4651




Company News
NeoStem, Inc. Announces Dr. Merrick Ross Of MD Anderson Cancer Center As Lead Principal Investigator For Pivotal Phase III Trial For Metastatic Melanoma 5/26/2015 6:39:58 AM
Turning Cancer Against Itself: Major Grant Advances Pioneering Melanoma Therapy At NeoStem, Inc. 5/21/2015 1:23:51 PM
NeoStem, Inc. Announces 2015 First Quarter Financial Results And Provides Corporate Update 5/5/2015 10:16:53 AM
NeoStem, Inc. To Present At Multiple May And June Conferences 5/4/2015 10:47:07 AM
NeoStem, Inc. Announces First Patient Randomized In Pivotal Phase III Melanoma Immunotherapy Clinical Trial 4/30/2015 7:20:22 AM
Cryoport Supports NeoStem, Inc.'s Intus Study For The Treatment Of Metastatic Melanoma 4/29/2015 12:00:12 PM
NeoStem, Inc.'s Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From The European Medicines Agency 4/27/2015 8:29:29 AM
NeoStem, Inc. Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma (KITE) 4/20/2015 8:07:07 AM
NeoStem, Inc. Announces Extension Of Study Under Grant From California Institute Of Regenerative Medicine (CIRM) To Fund Research Of Retinal Disease 4/9/2015 5:59:36 AM
NeoStem, Inc. To Present At Multiple April Conferences 4/6/2015 7:27:17 AM